GRANULES vs SAILIFE: Stock Comparison

GRANULES INDIA vs SAI LIFE SCIENCESUpdated 8 Oct 26, 4:08 PM ISTNSE & company filings

SAI LIFE SCIENCES is the larger company by market capitalisation. GRANULES INDIA shows a lower P/E, a higher dividend yield and faster revenue growth, while SAI LIFE SCIENCES shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GRANULES leads 8; SAILIFE leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GRANULESSAILIFE

Valuation lens

What price are you paying?

Market CapContext only
₹22,150 Cr
₹31,948 Cr
P/E RatioGRANULES has the lower reading
30.11x ✓
87.85x
P/B RatioGRANULES has the lower reading
3.96x ✓
12.82x
EPSGRANULES has the higher reading
₹7.26 ✓
₹3.36
Book ValueContext only
₹205.21
₹117
Dividend YieldGRANULES has the higher reading
0.22% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SAILIFE is the larger company
₹31,948 Cr vs ₹22,150 Cr
P/E Ratio
GRANULES has a lower P/E
30.11x vs 87.85x
P/B Ratio
GRANULES has a lower P/B
3.96x vs 12.82x
EPS
GRANULES has higher earnings per share
₹7.26 vs ₹3.36
Dividend Yield
GRANULES has a higher dividend yield
0.22% vs 0%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs 3.9%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs 17.6%
Qtr Sales Growth
GRANULES has stronger quarterly sales growth
84.16% vs -1.36%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESSAILIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESSAILIFE
Live Price₹815.05₹1,505.6
Day Change-3.58%-3.6%
Volume6.71 L5.14 L
52-Week High₹923.65₹1,697
52-Week Low₹529.85₹783.85
Distance from 52W High-11.76%-11.28%

Valuation

MetricGRANULESSAILIFE
Market Cap₹22,150 Cr₹31,948 Cr
P/E Ratio30.11x87.85x
P/B Ratio3.96x12.82x
EPS₹7.26₹3.36
Book Value₹205.21₹117
Dividend Yield0.22%0%

Growth

MetricGRANULESSAILIFE
Revenue Growth (TTM YoY)22.8%3.9%
EPS Growth (TTM YoY)31.3%17.6%
Qtr Sales Growth84.16%-1.36%
Qtr Profit Growth150.83%-2.66%

Profitability & Leverage

MetricGRANULESSAILIFE
ROE11.7%13.62%
ROCE12.47%14.49%
Net Margin11.15%15.81%
Operating Margin16.76%22.7%
Debt to Equity0.26x0.04x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricGRANULESSAILIFE
Promoter Holding37.08%▼ 0.59 pp32.87%▼ 0.08 pp
FII Holding20.29%▲ 2.79 pp19.65%▼ 1.52 pp
DII Holding15.4%▼ 0.71 pp32.71%▲ 1.17 pp
Public Holding26.93%▼ 1.45 pp13.11%▲ 0.43 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRANULES INDIA and SAI LIFE SCIENCES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.